Daré Bioscience, Inc.DARENASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-36.4%
5Y CAGR-17.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-36.4%/yr
vs +47.1%/yr prior
5Y CAGR
-17.9%/yr
Recent deceleration
Acceleration
-83.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.73M | -45.6% |
| 2024 | $14.21M | -34.0% |
| 2023 | $21.54M | -28.3% |
| 2022 | $30.04M | -1.9% |
| 2021 | $30.62M | +47.4% |
| 2020 | $20.77M | +143.0% |
| 2019 | $8.55M | +33.2% |
| 2018 | $6.41M | +551.3% |
| 2017 | $984749.00 | -96.4% |
| 2016 | $27.57M | - |